Acquiring Company
AbbVie Inc.
Acquired Company
DJS Antibodies
North ChicagoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaDescription
AbbVie (NYSE: ABBV) today announced the acquisition of DJS Antibodies Ltd ("DJS"), a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs). DJS's lead program is DJS-002, a potential first-in-class lysophosphatidic acid (LPA) receptor 1 (LPAR1) antagonist antibody currently in investigational preclinical studies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic diseases. IPF is an aggressive, high mortality disease caused by fibrotic scarring in the lungs and remains an area of high unmet medical need.
Quick answer
AbbVie Inc. is acquiring DJS Antibodies, announced October 20, 2022. AbbVie Inc. is based in North Chicago, Illinois, United States.
- How much did AbbVie Inc. pay for DJS Antibodies?
- The deal value was not disclosed.
- What does AbbVie Inc. do?
- Venture capital subsidiary of Abbvie
- Where are AbbVie Inc. and DJS Antibodies based?
- AbbVie Inc. is based in North Chicago, Illinois, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Merck To Acquire Imago Biosciences, Inc. (November 21, 2022)
- Atossa Therapeutics, Inc. To Acquire Stake In Privately Held Dynamic Cell Therapies As Part Of Overall Car-T Strategy (November 1, 2022)
- Pfizer Completes Acquisition Of Global Blood Therapeutics (October 5, 2022)
- Pfizer Completes Acquisition Of Biohaven Pharmaceuticals (October 3, 2022)
- Sumitovant Biopharma And Sumitomo Pharma Announce Offer To Acquire Outstanding Shares Of Myovant Sciences (October 2, 2022)
- Lilly Completes Acquisition Of Akouos Expanding Efforts To Help People With Genetic Diseases (December 1, 2022)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired DJS Antibodies?
DJS Antibodies was acquired by AbbVie Inc., based in North Chicago. The deal was reported on October 20, 2022. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire DJS Antibodies?
AbbVie Inc.'s acquisition of DJS Antibodies was reported on October 20, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does DJS Antibodies do?
DJS Antibodies is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.